Horizon Technology Finance Provides $15 Million Loan Facility to Bioness Medical

Corporate Action
โดย Business Wire·US·Read original
Summary · why it matters

Horizon Technology Finance Corporation, an affiliate of Monroe Capital, has provided a $15 million senior credit facility to Bioness Medical, Inc., with an initial $10 million funded at closing and up to $5 million available to support Bioness's continued growth. Bioness develops FDA-approved neurorehabilitation technologies for individuals recovering from stroke, spinal cord injury, and other neurological conditions, and is backed by Accelmed Partners. Horizon's Chief Investment Officer, Paul Seitz, highlighted the company's focus on providing flexible growth capital to innovative companies with proven business models, while Bioness's CEO, Todd Cushman, noted the facility offers additional capital and flexibility for expanding its product portfolio and serving patients globally.

Impact on stocks 2

Financials▲ · 1 stocks
Others▲ · 1 stocks

Off-coverage companies 3

Bioness Medical, Inc.Private▲ Positive
Capitalrelevance

Bioness Medical secures a $15M credit facility with $10M funded to support its growth and product expansion.

Monroe Capital LLCPrivate▲ Positive
Capitalrelevance

Monroe Capital affiliate Horizon Technology Finance originated the $15M credit facility.

Accelmed PartnersPrivate± Mixed
relevance

© 2026 MarketDXNews